Correlation Between LAVA Medtech and FTAC Emerald

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both LAVA Medtech and FTAC Emerald at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LAVA Medtech and FTAC Emerald into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LAVA Medtech Acquisition and FTAC Emerald Acquisition, you can compare the effects of market volatilities on LAVA Medtech and FTAC Emerald and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LAVA Medtech with a short position of FTAC Emerald. Check out your portfolio center. Please also check ongoing floating volatility patterns of LAVA Medtech and FTAC Emerald.

Diversification Opportunities for LAVA Medtech and FTAC Emerald

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between LAVA and FTAC is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding LAVA Medtech Acquisition and FTAC Emerald Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FTAC Emerald Acquisition and LAVA Medtech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LAVA Medtech Acquisition are associated (or correlated) with FTAC Emerald. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FTAC Emerald Acquisition has no effect on the direction of LAVA Medtech i.e., LAVA Medtech and FTAC Emerald go up and down completely randomly.

Pair Corralation between LAVA Medtech and FTAC Emerald

If you would invest  1,051  in FTAC Emerald Acquisition on September 1, 2024 and sell it today you would earn a total of  149.00  from holding FTAC Emerald Acquisition or generate 14.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.53%
ValuesDaily Returns

LAVA Medtech Acquisition  vs.  FTAC Emerald Acquisition

 Performance 
       Timeline  
LAVA Medtech Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
FTAC Emerald Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FTAC Emerald Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, FTAC Emerald is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

LAVA Medtech and FTAC Emerald Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with LAVA Medtech and FTAC Emerald

The main advantage of trading using opposite LAVA Medtech and FTAC Emerald positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LAVA Medtech position performs unexpectedly, FTAC Emerald can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FTAC Emerald will offset losses from the drop in FTAC Emerald's long position.
The idea behind LAVA Medtech Acquisition and FTAC Emerald Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Directory
Find actively traded commodities issued by global exchanges